ALLMedicine™ Percutaneous Liver Biopsy Center
Research & Reviews 127 results
https://clinicaltrials.gov/ct2/show/NCT03520660
May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...
https://doi.org/10.1007/s00330-022-08572-2 10.1055/s-0033-1350114 10.1371/journal.pone.0122181 10.7863/ultra.34.4.627 10.5505/tjtes.2011.89914 10.1111/echo.14451 10.1016/j.amjcard.2005.05.060 10.1093/ehjci/jey145 10.1007/s11739-016-1406-x 10.1016/j.jhep.2008.07.039 10.1136/gut.2005.068585 10.1016/S1665-2681(19)31456-5 10.1136/gut.2007.135046 10.1016/S0168-8278(99)80107-X 10.1148/radiol.2272020193 10.1136/gut.2006.111302 10.3350/cmh.2013.19.4.389 10.1148/radiol.2016151542 10.1016/j.ejro.2017.07.001 10.1002/jmri.25911 10.3233/WOR-172611 10.1111/jgh.13762 10.1097/00042737-200604000-00015
European Radiology; Costantino A, Piagnani A et. al.
Mar 4th, 2022 - Fibrosis is the key prognostic factor in chronic liver disease patients. Liver surface nodularity (LSN) is the ultrasonographic sign with the highest accuracy to detect advanced liver fibrosis. The use of pocket-sized ultrasound devices (PUDs) has...
https://doi.org/10.1007/s10620-022-07399-7 10.1002/hep.22742 10.1016/S0002-9270(01)02339-5 10.1111/j.1440-1746.1994.tb01274.x 10.1055/s-0034-1391412 10.1016/j.gie.2018.10.018 10.1016/j.gie.2014.11.023 10.1002/hep.20701 10.1007/s10620-016-4062-0 10.1055/a-1165-1767 10.1055/a-0967-3640 10.1007/s40477-020-00436-z
Digestive Diseases and Sciences; Saraireh H, Abdelfattah T et. al.
Feb 17th, 2022 - Endoscopic ultrasound-guided liver biopsy (EUS-LB) has emerged as a viable mean to obtain core tissue, but the optimal tools and techniques are still an area of active investigation. (1) To compare tissue adequacy using "wet saline" (WS) vs. "wet ...
https://doi.org/10.1007/s11605-021-05197-6 10.1056/NEJM199910283411807 10.1093/annonc/mdn533 10.1002/cncr.11105 10.1634/theoncologist.2007-0252 10.1016/S1470-2045(14)70212-8 10.1007/s11894-011-0178-8 10.1097/01.sla.0000251366.62632.d3 10.1038/70932 10.1038/nm730 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9 10.1084/jem.192.7.1027 10.1056/NEJMoa1200694 10.18632/oncotarget.18316 10.1126/science.aan6733 10.1002/cam4.1372 10.1016/S0140-6736(15)01281-7 10.1038/nature14011 10.1158/1078-0432.CCR-13-3271 10.1016/j.ctrv.2015.11.001 10.1186/s12885-018-5254-0 10.1111/his.13238 10.3892/ol.2017.6105 10.1200/JCO.19.02105 10.1200/JCO.2018.78.2276 10.1002/ijc.33013 10.21037/jgo.2019.08.08 10.18632/oncotarget.15602 10.1007/s00535-019-01586-6 10.1016/S0016-5107(02)70442-2 10.1016/S0016-5107(02)70123-5
Journal of Gastrointestinal Surgery : Official Journal Of... Matsumoto K, Ohara T et. al.
Feb 10th, 2022 - Anti-programmed death 1/programmed death ligand 1 (PD1/PD-L1) antibodies have been successfully used as treatment agents for several solid tumors; however, it is difficult to predict their effectiveness. We evaluated whether biopsy specimens could...
https://doi.org/10.1097/MEG.0000000000002080
European Journal of Gastroenterology & Hepatology; Mulazzani L, Terzi E et. al.
Jan 21st, 2022 - Ultrasound-guided percutaneous liver biopsy is a standard procedure, but it might be burdened with serious adverse events, mainly hemorrhagic. Literature lacks recent studies taking into account new ultrasound machines, more sensitive to tiny vess...
Clinicaltrials.gov 8 results
https://clinicaltrials.gov/ct2/show/NCT03520660
May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...
https://clinicaltrials.gov/ct2/show/NCT03864744
Oct 4th, 2021 - After total pancreatectomy patients are treated with exogenous insulin and pancreatic enzyme supplementation in order to treat the endocrine and exocrine insufficiencies inherently occurring postoperatively. In addition to secondary diabetes and i...
https://clinicaltrials.gov/ct2/show/NCT03289897
Mar 4th, 2021 - Non-alcoholic fatty liver disease (NAFLD) is a condition associated with obesity, insulin resistance and heart disease. Research has shown that fatty liver (steatosis) can lead to a spectrum of diseases including low grade inflammation (steatohepa...
https://clinicaltrials.gov/ct2/show/NCT03408171
Apr 14th, 2020 - Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an important method for helping to determine the etiolo...
https://clinicaltrials.gov/ct2/show/NCT03373643
Jan 16th, 2019 - Obstructive sleep apnea (OSA) and nonalcoholic fatty liver disease (NAFLD) are frequently encountered in patients with metabolic syndrome (MS). Several data suggest that OSA per se could be a risk factor of liver injury. Most previous studies eval...
News 2 results
https://www.medpagetoday.com/rheumatology/generalrheumatology/50768
Apr 1st, 2015 - Action Points This consensus statement provides guidance for clinicians facing IgG4-related diseases, a relatively novel classification. Be aware that much of the evidence for managment of these related conditions are not informed by clinical tria...
https://www.medscape.com/viewarticle/931599_2
Imaging Findings An initial ultrasound scan revealed a diffusely coarsened and heterogenous echotexture throughout the liver with a nodular contour but no discrete mass (Figure 1). In addition to the abnormal hepatic parenchyma, there was mild gal...
